Results 271 to 280 of about 3,269,240 (334)
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
Nanoporous anodic alumina-based gas sensors: insights into advances and perspectives. [PDF]
Tran KN+4 more
europepmc +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source
Caracterización química y sensorial del aroma del calamar del genero Illex Argentinus
Vanesa Carrascón+2 more
openalex +2 more sources
Design and optimization of a compact dual band metal insulator metal filter for high sensitivity refractive index sensing using particle swarm optimization. [PDF]
Darabi A, Malekshahi MR.
europepmc +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
Super-resolution tactile sensor arrays with sparse units enabled by deep learning. [PDF]
Kong D+10 more
europepmc +1 more source